Imiquimod 5% cream for the treatment of actinic keratosis: Results from a phase III, randomized, double-blind, vehicle-controlled, clinical trial with histology
Top Cited Papers
Open Access
- 31 October 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 51 (4), 547-555
- https://doi.org/10.1016/j.jaad.2004.02.022
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Imiquimod 5% cream for the treatment of actinic keratosis: results from two phase III, randomized, double-blind, parallel group, vehicle-controlled trialsJournal of the American Academy of Dermatology, 2004
- Nudging Epidermal Field Cancerogenesis by ImiquimodDermatology, 2003
- Incidental Histopathologic Patterns: Possible Evidence of `Field Cancerization' Surrounding Skin TumorsThe American Journal of Dermatopathology, 2001
- Cytokine Induction in Hairless Mouse and Rat Skin After Topical Application of the Immune Response Modifiers Imiquimod and S-28463Journal of Investigative Dermatology, 1998
- Advances in the understanding of malignant transformation of keratinocytes: an immunohistochemical studyJournal of the European Academy of Dermatology and Venereology, 1998
- Randomised, double-blind, placebo-controlled trial of interferon α-2b with and without ribavirin for chronic hepatitis CThe Lancet, 1998
- Self-administered Topical 5% Imiquimod Cream for External Anogenital WartsArchives of Dermatology, 1998
- Actinic keratosesJournal of the American Academy of Dermatology, 1997
- Interferons and Collagen ProductionJournal of Investigative Dermatology, 1990
- Gamma interferon is the lymphokine and beta interferon the monokine responsible for inhibition of fibroblast collagen production and late but not early fibroblast proliferation.The Journal of Experimental Medicine, 1985